ebomi
Colour theme
Sign in
Insider · CIK 0001282930

Gordon Carl L

CIK 0001282930 Name as filed on the most recent filing

Filed as Gordon Carl L (58)

160 transaction lines · from 58 filings · filed 2004-06-04 to 2026-08-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

158 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-05-13 P, Open-market purchase Compass Therapeutics, Inc.CMPX 76,498, acquired Open Form 4 filing 0000947871-22-000568
2022-05-12 P, Open-market purchase Compass Therapeutics, Inc.CMPX 228,171, acquired Open Form 4 filing 0000947871-22-000568
2022-05-11 P, Open-market purchase Compass Therapeutics, Inc.CMPX 115,813, acquired Open Form 4 filing 0000947871-22-000568
2022-05-10 P, Open-market purchase Compass Therapeutics, Inc.CMPX 39,115, acquired Open Form 4 filing 0000947871-22-000539
2022-05-09 P, Open-market purchase Compass Therapeutics, Inc.CMPX 141,511, acquired Open Form 4 filing 0000947871-22-000539
2022-05-06 P, Open-market purchase Compass Therapeutics, Inc.CMPX 16,626, acquired Open Form 4 filing 0000947871-22-000539
2022-02-15 P, Open-market purchase Kinnate Biopharma Inc.KNTE 89,640, acquired Open Form 4 filing 0000947871-22-000255
2022-02-14 P, Open-market purchase Kinnate Biopharma Inc.KNTE 2 lines 305,486, acquired Open Form 4 filing 0000947871-22-000255
2022-02-11 P, Open-market purchase Kinnate Biopharma Inc.KNTE 1,594,320, acquired Open Form 4 filing 0000947871-22-000255
2022-01-21 P, Open-market purchase Theseus Pharmaceuticals, Inc.THRX 1,115,603, acquired Open Form 4 filing 0000947871-22-000088
2022-01-20 P, Open-market purchase Theseus Pharmaceuticals, Inc.THRX 348,250, acquired Open Form 4 filing 0000947871-22-000088
2022-01-19 P, Open-market purchase Theseus Pharmaceuticals, Inc.THRX 114,864, acquired Open Form 4 filing 0000947871-22-000088
2022-01-13 P, Open-market purchase Theseus Pharmaceuticals, Inc.THRX 163,328, acquired Open Form 4 filing 0000947871-22-000050
2022-01-12 P, Open-market purchase Theseus Pharmaceuticals, Inc.THRX 190,104, acquired Open Form 4 filing 0000947871-22-000050
2022-01-11 P, Open-market purchase Theseus Pharmaceuticals, Inc.THRX 2 lines 89,319, acquired Open Form 4 filing 0000947871-22-000050
2021-11-04 P, Open-market purchase Compass Therapeutics, Inc.CMPX 2 lines 18,750,001, acquired Open Form 4 filing 0000947871-21-001151
2021-10-12 P, Open-market purchase Theseus Pharmaceuticals, Inc.THRX 2 lines 10,000,000, acquired Open Form 4 filing 0000899243-21-040256
2021-03-30 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 666,905, disposed Open Form 4 filing 0000947871-21-000400
2021-03-29 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 1,761,187, disposed Open Form 4 filing 0000947871-21-000400
2021-03-26 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 664,246, disposed Open Form 4 filing 0000947871-21-000395
2021-03-25 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 1,272,618, disposed Open Form 4 filing 0000947871-21-000395
2021-03-24 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 817,383, disposed Open Form 4 filing 0000947871-21-000395
2021-03-23 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 97,085, disposed Open Form 4 filing 0000947871-21-000361
2021-03-22 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 203,104, disposed Open Form 4 filing 0000947871-21-000361
2021-03-19 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 563,149, disposed Open Form 4 filing 0000947871-21-000361
2021-03-18 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 169,834, disposed Open Form 4 filing 0000947871-21-000348
2021-03-17 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 534,200, disposed Open Form 4 filing 0000947871-21-000348
2021-03-16 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 1,146,305, disposed Open Form 4 filing 0000947871-21-000348
2021-03-15 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 2,599,579, disposed Open Form 4 filing 0000947871-21-000333
2021-03-12 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 2,741,881, disposed Open Form 4 filing 0000947871-21-000333
2021-03-11 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 1,934,525, disposed Open Form 4 filing 0000947871-21-000333
2021-02-09 P, Open-market purchase Terns Pharmaceuticals, Inc.TERN 2 lines 8,075,000, acquired Open Form 4 filing 0001567619-21-002593
2020-12-02 P, Open-market purchase Kinnate Biopharma Inc.KNTE 2 lines 15,000,000, acquired Open Form 4 filing 0001140361-20-027382
2020-06-19 P, Open-market purchase Compass Therapeutics, Inc.NONE 7,275,660, acquired Open Form 4 filing 0001213900-20-015636
2020-04-24 P, Open-market purchase Oric Pharmaceuticals, Inc.ORIC 4,500,000, acquired Open Form 4 filing 0001209191-20-025983
2020-04-13 P, Open-market purchase Keros Therapeutics, Inc.KROS 6,003,200, acquired Open Form 4 filing 0001209191-20-024225
2019-06-24 P, Open-market purchase Prevail Therapeutics Inc.PRVL 14,999,984, acquired Open Form 4 filing 0001209191-19-039127
2019-04-22 P, Open-market purchase Turning Point Therapeutics, Inc.TPTX 6,480,000, acquired Open Form 4 filing 0001209191-19-025791
2019-02-11 P, Open-market purchase Alector, Inc.ALEC 3 lines 7,822,300, acquired Open Form 4 filing 0001209191-19-009111
2017-11-20 P, Open-market purchase Arsanis, Inc.ASNS 5,000,000, acquired Open Form 4 filing 0000899243-17-027002
2016-06-27 P, Open-market purchase Selecta Biosciences IncSELB 2 lines 7,700,000, acquired Open Form 4 filing 0001104659-16-130152

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 84
  • Open-market sale 74
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. GORDON CARL L, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001282930

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.